Category: CV Sciences

analysis, analytics, bad actors, batch, business, cannabinoid, cannabis, cbd, CEO, certificate of analysis, CGMP, claim, COA, compliance, composition, consumer, contents, CV Sciences, dietary, extraction, FDA, Federal, GMP, good manufacturing practices, government, growing, ID, identity, industry, ingredient, Joseph Dowling, lab, label, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, lot, marijuana, market, medical, medicine, number, packaging, potency, product, purity, Quality, regulation, regulations, regulatory, retail, safety, serving, size, state, strength, Testing, thc, unsubstantiated

Bad Actors in CBD: How to Distinguish Quality Products From the Rest

Bad Actors in CBD: How to Distinguish Quality Products From the Rest

The success of reputable cannabis and CBD brands has inspired an influx of inexperienced and disreputable competitors in the market. These so-called […]

analysis, analytics, asset, balance, business, Business Analysis, cannabidiol, cannabis, cap, capitalization, cash, cbd, Charlotte's Web, compliance, Concentrates & Extracts, consumer, cultivation, CV Sciences, CVSI, Dispensaries & Retail, dispensary, distribution, distributor, Edibles & Processing, extraction, farm bill, Federal, finance, financial, gold rush, government, growing, hemp, industry, international, law, legal, legalization, license, light, marijuana, market, oil, Operations, PLUS, product, Product Development, Quality, recreational, regulation, regulatory, retail, revenue, state, Sunsoil, test

The CBD Gold Rush Is Over & It’s Great for Consumers

The CBD Gold Rush Is Over & It’s Great for Consumers

Disclaimer: I am not a financial advisor. Nothing contained in this post should be construed as investment advice. CV Sciences ($CVSI), the company […]

administration, aid, analysis, analytics, and Economic Security Act, assistance, business, Business Analysis, cannabis, CARES Act, cbd, CBDMd, companies, compliance, controlled substance, Coronavirus, COVID, COVID-19, cultivation, CV Sciences, Dispensaries & Retail, dispensary, extraction, Federal, financial, government, growing, hemp, industry, law, legal, legalization, legalize, legislation, license, lifted made, marijuana, market, MED, medical, medicine, money, pandemic, PPP, product, products, Quality, rec, recreational, regulation, regulations, regulatory, relief, SBA, schedule, schedule 1, small, state, thc, Trump, VICE

Some CBD Companies Are Getting Millions in Federal Aid

Some CBD Companies Are Getting Millions in Federal Aid

As we’ve covered previously, the coronavirus pandemic has impacted the cannabis industry in the United States in a number of ways. Many […]